Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

3 Tech Stocks I’m Growing More and More Bullish On

By Chris MacDonald, InvestorPlace Contributor

Three top tech stocks that I'm growing increasingly bullish on as ways to play growth in this uncertain time.

3 Cryptos That Actually Have a Solid Investing Thesis

By Chris MacDonald, InvestorPlace Contributor

Three top, high-quality cryptos to buy are meant for long-term investors looking to build positions in this current market.

NVDA Stock Forecast: Is the Next 10% Up or Down for Nvidia?

By Chris MacDonald, InvestorPlace Contributor

Nvidia remains a highly-valued tech giant, but can the company continue to prove to investors that its current multiple makes sense?

3 High-Growth Stocks to Send Your Portfolio Skyrocketing

By Chris MacDonald, InvestorPlace Contributor

For investors seeking high-growth stocks in this volatile market, there are few decent options. Here are three worth buying.

Up, Up, and Away: JOBY Aviation’s Stock Surge and What Lies Ahead

By Chris MacDonald, InvestorPlace Contributor

Here are just a few of the reasons why investors may want to consider Joby Aviation and JOBY stock when it comes to eVTOL plays.

Why Is Li-Cycle (LICY) Stock Down 40% Today?

By Chris MacDonald, InvestorPlace Contributor

Here's what investors in Li-Cycle are bemoaning today, as shares of LICY stock fall off a cliff, dropping more than 40% today.

Why Is INVO Bioscience (INVO) Stock Up 325% Today?

By Chris MacDonald, InvestorPlace Contributor

Here's what investors in INVO Bioscience may want to know, as INVO stock absolutely skyrockets more than 325% in today's session.

Buy the PYPL Dip? Why PayPal’s Decline Might Be a Golden Opportunity

By Chris MacDonald, InvestorPlace Contributor

There are plenty of speculative names within the fintech sector investors should be cautious of. PayPal and PYPL stock aren't one.

Tesla’s Financial Detour: Warning Signs Every Investor Should Heed

By Chris MacDonald, InvestorPlace Contributor

The world of EV stocks is as vast as it is complicated. Here's why investors may want to look past TSLA stock in this space right now.

The GOOG Gold Rush: Why Analysts are Betting Big on Alphabet

By Chris MacDonald, InvestorPlace Contributor

Here's why investors should keep an eye on Alphabet and GOOG stock, in this very uncertain market right now.

Load More